Corient Private Wealth LP Buys New Shares in Ralliant Corporation $RAL

Corient Private Wealth LP bought a new position in Ralliant Corporation (NYSE:RAL) in the 2nd quarter, Holdings Channel.com reports. The fund bought 34,905 shares of the company’s stock, valued at approximately $2,570,000.

Other hedge funds also recently bought and sold shares of the company. Cetera Investment Advisers purchased a new stake in Ralliant in the 2nd quarter worth $700,000. Russell Investments Group Ltd. purchased a new position in shares of Ralliant in the second quarter valued at about $1,465,000. EverSource Wealth Advisors LLC purchased a new position in shares of Ralliant in the second quarter valued at about $39,000. First Trust Advisors LP purchased a new position in shares of Ralliant in the second quarter valued at about $2,013,000. Finally, Federated Hermes Inc. bought a new position in shares of Ralliant in the second quarter worth about $326,000.

Wall Street Analyst Weigh In

RAL has been the subject of several recent analyst reports. Morgan Stanley upped their price target on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. Oppenheimer lifted their price objective on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. BMO Capital Markets began coverage on shares of Ralliant in a report on Monday, July 20th. They issued a “market perform” rating and a $78.00 target price on the stock. Barclays upped their target price on shares of Ralliant from $52.00 to $67.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 13th. Finally, Wall Street Zen cut shares of Ralliant from a “strong-buy” rating to a “buy” rating in a research note on Sunday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.70.

Insider Buying and Selling at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction on Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the transaction, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. This trade represents a 4.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by company insiders.

Ralliant Stock Performance

NYSE:RAL opened at $61.61 on Thursday. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. Ralliant Corporation has a 1 year low of $37.27 and a 1 year high of $75.41. The stock’s 50 day simple moving average is $67.91 and its two-hundred day simple moving average is $56.92. The company has a market cap of $6.82 billion, a price-to-earnings ratio of -5.68, a PEG ratio of 2.27 and a beta of 1.54.

Ralliant (NYSE:RAL) last posted its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts anticipate that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is presently -1.84%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.